Longitudinal change of circulating tumor cell level and its relationship with immune checkpoint inhibitor-based treatment benefits in unresectable, metastatic colorectal cancer patients.

Fan, Hua; Bai, Lang; Bai, Kai

Fan, Hua; Bai, Lang; Bai, Kai.

Fan H; Department of Gastrointestinal Surgery, Yanan University Affilliated Hospital, Yanan, Shanxi, China.
Bai L; Department of Gastrointestinal Surgery, Yanan University Affilliated Hospital, Yanan, Shanxi, China.
Bai K; Department of Gastrointestinal Surgery, Yanan University Affilliated Hospital, Yanan, Shanxi, China.

Scand J Clin Lab Invest ; 83(4): 227-233, 2023 07.

Article en En | MEDLINE | ID: mdl-37247200

Asunto(s)

Neoplasias del Colon; Células Neoplásicas Circulantes; Humanos; Células Neoplásicas Circulantes/patología; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Biomarcadores de Tumor; Resultado del Tratamiento; Pronóstico

Palabras clave

Metastatic colorectal cancer; circulating tumor cell; longitudinal change; prognosis; treatment response

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Colon / Células Neoplásicas Circulantes Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google